APA

Kasow K. A., Stewart C. F., Barfield R. C., Wright N. L., Li C., Srivastava D. K., Leung W., Horwitz E. M., Bowman L. C., Handgretinger R. & Hale G. A. (20130705). A phase I/II study of CY and topotecan in patients with high-risk malignancies undergoing autologous hematopoietic cell transplantation: the St Jude long-term follow-up. : Bone marrow transplantation.

Chicago

Kasow K A, Stewart C F, Barfield R C, Wright N L, Li C, Srivastava D K, Leung W, Horwitz E M, Bowman L C, Handgretinger R and Hale G A. 20130705. A phase I/II study of CY and topotecan in patients with high-risk malignancies undergoing autologous hematopoietic cell transplantation: the St Jude long-term follow-up. : Bone marrow transplantation.

Harvard

Kasow K. A., Stewart C. F., Barfield R. C., Wright N. L., Li C., Srivastava D. K., Leung W., Horwitz E. M., Bowman L. C., Handgretinger R. and Hale G. A. (20130705). A phase I/II study of CY and topotecan in patients with high-risk malignancies undergoing autologous hematopoietic cell transplantation: the St Jude long-term follow-up. : Bone marrow transplantation.

MLA

Kasow K A, Stewart C F, Barfield R C, Wright N L, Li C, Srivastava D K, Leung W, Horwitz E M, Bowman L C, Handgretinger R and Hale G A. A phase I/II study of CY and topotecan in patients with high-risk malignancies undergoing autologous hematopoietic cell transplantation: the St Jude long-term follow-up. : Bone marrow transplantation. 20130705.